| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |